Alpelisib-Induced Diabetic Ketoacidosis and Insulin-Resistant Hyperglycemia

Background/Objective: Alpelisib is a phosphatidylinositol 3-kinase inhibitor used to treat certain hormone therapy resistant breast cancers that can cause hyperglycemia through inhibition of the insulin signaling cascade. Diabetic ketoacidosis with the initiation of alpelisib remains a rare complica...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Loke, DO, Vishal Sehgal, MD, Niraj Gupta, MD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:AACE Clinical Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060524001111
Tags: Add Tag
No Tags, Be the first to tag this record!